High versus low-dose cisplatin combined with vinblastine and bleomycin and selective surgical resection of residual disease in patients with disseminated testicular cancer: a Southwest Oncology Group Study.
Crawford
E D
ED
Samson
M
M
Klugo
R C
RC
Dawkins
C A
CA
Davis
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001761:Bleomycin / Q000009:adverse effects / Q000627:therapeutic use; D002945:Cisplatin / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D011897:Random Allocation; D012187:Retroperitoneal Space; D013736:Testicular Neoplasms / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D014747:Vinblastine / Q000009:adverse effects / Q000627:therapeutic use
D001761:Bleomycin; D014747:Vinblastine; D002945:Cisplatin